Page 4 - Polypipe Group News Today

MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS DIRECTED ONLY AT PERSONS WHOSE ORDINARY ACTIVITIES INVOLVE THEM IN ACQUIRING, HOLDING, MANAGING AND DISPOSING OF INVESTMENTS (AS PRINCIPAL OR AGENT) FOR THE PURPOSES OF THEIR BUSINESS AND WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS AND ARE: (A) IF IN A MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (THE "EEA"), QUALIFIED INVESTORS WITHIN T...

+44 (0) 20 7404 5959 This Announcement should be read in its entirety. In particular, you should read and understand the information provided in the "Important Notices" section of this Announcement. IMPORTANT NOTICES This Announcement and the information contained in it is restricted and is not for release, publication, distribution or forwarding, in whole or in part, directly or indirectly, in or into any jurisdiction in which such publication, release or distri...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

European Stocks Higher On U.S. Vaccine Approval, Extended Brexit Talks BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks traded higher on Monday, despite mixed Asian cues, following news that the United States will start Covid-19 vaccinations today after the drug regulators approved the Pfizer- BioNTechs COVID-19 vaccine. The U.S. Centers for Disease Control and Prevention or CDC, gave the approval for Pfizer- BioNTechs COVID-19 vaccine, following the Emergency Use Authorization or EUA issue...